Table 3.
TAPS Group at 3-Month Follow-Up
| Post-Treatment (n = 20) | Follow-up (n = 20) | |||||
|---|---|---|---|---|---|---|
| Variable | n | (%) | n | (%) | ||
| Principal diagnosis (present) | 11 | (55) | 9 | (45) | ||
| Any comorbid diagnosis (present) | 8 | (40) | 5 | (25) | ||
|
| ||||||
| M | (SD) | M | (SD) | t(1) | pa | |
|
| ||||||
| Principal diagnosis severity rating (0 – 8) | 3.6 | (1.7) | 3.1 | (1.9) | 1.9 | .07 |
| Self-ratings | ||||||
| Pain (0–8) | 1.6 | (1.5) | 1.7 | (1.7) | −.65 | .53 |
| GI-CSI (0–24) | 4.3 | (5.4) | 4.0 | (4.2) | .49 | .63 |
| Parent ratings | ||||||
| Pain (0–8) | 2.3 | (1.6) | 2.0 | (1.4) | .88 | .39 |
| Independent evaluator ratings | ||||||
| CGAS (1–100) | 67.3 | (12.2) | 71.0 | (11.1) | −1.8 | .09 |
Note. TAPS = Treatment of Anxiety and Physical Symptoms program group. WL = waiting-list control group. GI-CSI = Gastrointestinal Factor of Children’s Somatization Inventory. CGAS = Children’s Global Assessment Scale.
a
None were significant.